Report Detail

Market Insights
Due to the COVID-19 pandemic, the global Approved COVID-19 Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.

The global main manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson&Johnson, Heat Biologics and Sanofi. etc. In 2021, the global six largest players have a share approximately % in terms of revenue.

The North America Approved COVID-19 Vaccines market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Approved COVID-19 Vaccines landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Component Viral Vaccines accounting for % of the Approved COVID-19 Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Adults segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

Segment Scope

An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including sales and revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.

Segment by Type

Component Viral Vaccines

Whole Virus Vaccines

Segment by Application

Adults

Children

Elderly

Regional Scope

This segment of the report offers a thorough regional study of the global Approved COVID-19 Vaccines market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate, revenue, and sales volume according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

Key Players

This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue and sales data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:

Moderna

CanSino Biologicals

Inovio Pharmaceuticals

Shenzhen Geno-Immune Medical Institute

GlaxoSmithKine

Pfizer

Johnson&Johnson

Heat Biologics

Sanofi

Frequently Asked Questions

Which application segment captured the leading share in the Approved COVID-19 Vaccines market?

How fragmented is the Approved COVID-19 Vaccines market?

Which are the key growth drivers in the Approved COVID-19 Vaccines market?

Which are the top strategies undertaken by the Approved COVID-19 Vaccines market players?

Which technological trends are likely to affect the Approved COVID-19 Vaccines market?

What is the expected Approved COVID-19 Vaccines market size by 2028?

Which companies are dominating the Approved COVID-19 Vaccines market?

Which region is projected to witness the fastest growth in the future?

What factors are restraining the Approved COVID-19 Vaccines market growth?

Which are the emerging companies in the Approved COVID-19 Vaccines market?


1 Approved COVID-19 Vaccines Market Overview

  • 1.1 Approved COVID-19 Vaccines Product Overview
  • 1.2 Approved COVID-19 Vaccines Market Segment by Type
  • 1.2.1 Component Viral Vaccines
  • 1.2.2 Whole Virus Vaccines
  • 1.3 Global Approved COVID-19 Vaccines Market Size by Type
  • 1.3.1 Global Approved COVID-19 Vaccines Market Size Overview by Type (2017-2028)
  • 1.3.2 Global Approved COVID-19 Vaccines Historic Market Size Review by Type (2017-2022)
  • 1.3.2.1 Global Approved COVID-19 Vaccines Sales Breakdown in Volume by Type (2017-2022)
  • 1.3.2.2 Global Approved COVID-19 Vaccines Sales Breakdown in Value by Type (2017-2022)
  • 1.3.2.3 Global Approved COVID-19 Vaccines Average Selling Price (ASP) by Type (2017-2022)
  • 1.3.3 Global Approved COVID-19 Vaccines Forecasted Market Size by Type (2023-2028)
  • 1.3.3.1 Global Approved COVID-19 Vaccines Sales Breakdown in Volume by Type (2023-2028)
  • 1.3.3.2 Global Approved COVID-19 Vaccines Sales Breakdown in Value by Type (2023-2028)
  • 1.3.3.3 Global Approved COVID-19 Vaccines Average Selling Price (ASP) by Type (2023-2028)
  • 1.4 Key Regions Market Size Segment by Type
  • 1.4.1 North America Approved COVID-19 Vaccines Sales Breakdown by Type (2017-2022)
  • 1.4.2 Europe Approved COVID-19 Vaccines Sales Breakdown by Type (2017-2022)
  • 1.4.3 Asia-Pacific Approved COVID-19 Vaccines Sales Breakdown by Type (2017-2022)
  • 1.4.4 Latin America Approved COVID-19 Vaccines Sales Breakdown by Type (2017-2022)
  • 1.4.5 Middle East and Africa Approved COVID-19 Vaccines Sales Breakdown by Type (2017-2022)
  • 2 Global Approved COVID-19 Vaccines Market Competition by Company

    • 2.1 Global Top Players by Approved COVID-19 Vaccines Sales (2017-2022)
    • 2.2 Global Top Players by Approved COVID-19 Vaccines Revenue (2017-2022)
    • 2.3 Global Top Players Approved COVID-19 Vaccines Price (2017-2022)
    • 2.4 Global Top Manufacturers Approved COVID-19 Vaccines Manufacturing Base Distribution, Sales Area, Product Type
    • 2.5 Approved COVID-19 Vaccines Market Competitive Situation and Trends
    • 2.5.1 Approved COVID-19 Vaccines Market Concentration Rate (2017-2022)
  • 2.5.2 Global 5 and 10 Largest Manufacturers by Approved COVID-19 Vaccines Sales and Revenue in 2021
  • 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Approved COVID-19 Vaccines as of 2021)
  • 2.7 Date of Key Manufacturers Enter into Approved COVID-19 Vaccines Market
  • 2.8 Key Manufacturers Approved COVID-19 Vaccines Product Offered
  • 2.9 Mergers & Acquisitions, Expansion
  • 3 Approved COVID-19 Vaccines Status and Outlook by Region

    • 3.1 Global Approved COVID-19 Vaccines Market Size and CAGR by Region: 2017 VS 2021 VS 2028
    • 3.2 Global Approved COVID-19 Vaccines Historic Market Size by Region
    • 3.2.1 Global Approved COVID-19 Vaccines Sales in Volume by Region (2017-2022)
  • 3.2.2 Global Approved COVID-19 Vaccines Sales in Value by Region (2017-2022)
  • 3.2.3 Global Approved COVID-19 Vaccines Sales (Volume & Value) Price and Gross Margin (2017-2022)
  • 3.3 Global Approved COVID-19 Vaccines Forecasted Market Size by Region
  • 3.3.1 Global Approved COVID-19 Vaccines Sales in Volume by Region (2023-2028)
  • 3.3.2 Global Approved COVID-19 Vaccines Sales in Value by Region (2023-2028)
  • 3.3.3 Global Approved COVID-19 Vaccines Sales (Volume & Value), Price and Gross Margin (2023-2028)
  • 4 Global Approved COVID-19 Vaccines by Application

    • 4.1 Approved COVID-19 Vaccines Market Segment by Application
    • 4.1.1 Adults
  • 4.1.2 Children
  • 4.1.3 Elderly
  • 4.2 Global Approved COVID-19 Vaccines Market Size by Application
  • 4.2.1 Global Approved COVID-19 Vaccines Market Size Overview by Application (2017-2028)
  • 4.2.2 Global Approved COVID-19 Vaccines Historic Market Size Review by Application (2017-2022)
  • 4.2.2.1 Global Approved COVID-19 Vaccines Sales Breakdown in Volume, by Application (2017-2022)
  • 4.2.2.2 Global Approved COVID-19 Vaccines Sales Breakdown in Value, by Application (2017-2022)
  • 4.2.2.3 Global Approved COVID-19 Vaccines Average Selling Price (ASP) by Application (2017-2022)
  • 4.2.3 Global Approved COVID-19 Vaccines Forecasted Market Size by Application (2023-2028)
  • 4.2.3.1 Global Approved COVID-19 Vaccines Sales Breakdown in Volume, by Application (2023-2028)
  • 4.2.3.2 Global Approved COVID-19 Vaccines Sales Breakdown in Value, by Application (2023-2028)
  • 4.2.3.3 Global Approved COVID-19 Vaccines Average Selling Price (ASP) by Application (2023-2028)
  • 4.3 Key Regions Market Size Segment by Application
  • 4.3.1 North America Approved COVID-19 Vaccines Sales Breakdown by Application (2017-2022)
  • 4.3.2 Europe Approved COVID-19 Vaccines Sales Breakdown by Application (2017-2022)
  • 4.3.3 Asia-Pacific Approved COVID-19 Vaccines Sales Breakdown by Application (2017-2022)
  • 4.3.4 Latin America Approved COVID-19 Vaccines Sales Breakdown by Application (2017-2022)
  • 4.3.5 Middle East and Africa Approved COVID-19 Vaccines Sales Breakdown by Application (2017-2022)
  • 5 North America Approved COVID-19 Vaccines by Country

    • 5.1 North America Approved COVID-19 Vaccines Historic Market Size by Country
    • 5.1.1 North America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
  • 5.1.2 North America Approved COVID-19 Vaccines Sales in Value by Country (2017-2022)
  • 5.2 North America Approved COVID-19 Vaccines Forecasted Market Size by Country
  • 5.2.1 North America Approved COVID-19 Vaccines Sales in Volume by Country (2023-2028)
  • 5.2.2 North America Approved COVID-19 Vaccines Sales in Value by Country (2023-2028)
  • 6 Europe Approved COVID-19 Vaccines by Country

    • 6.1 Europe Approved COVID-19 Vaccines Historic Market Size by Country
    • 6.1.1 Europe Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
  • 6.1.2 Europe Approved COVID-19 Vaccines Sales in Value by Country (2017-2022)
  • 6.2 Europe Approved COVID-19 Vaccines Forecasted Market Size by Country
  • 6.2.1 Europe Approved COVID-19 Vaccines Sales in Volume by Country (2023-2028)
  • 6.2.2 Europe Approved COVID-19 Vaccines Sales in Value by Country (2023-2028)
  • 7 Asia-Pacific Approved COVID-19 Vaccines by Region

    • 7.1 Asia-Pacific Approved COVID-19 Vaccines Historic Market Size by Region
    • 7.1.1 Asia-Pacific Approved COVID-19 Vaccines Sales in Volume by Region (2017-2022)
  • 7.1.2 Asia-Pacific Approved COVID-19 Vaccines Sales in Value by Region (2017-2022)
  • 7.2 Asia-Pacific Approved COVID-19 Vaccines Forecasted Market Size by Region
  • 7.2.1 Asia-Pacific Approved COVID-19 Vaccines Sales in Volume by Region (2023-2028)
  • 7.2.2 Asia-Pacific Approved COVID-19 Vaccines Sales in Value by Region (2023-2028)
  • 8 Latin America Approved COVID-19 Vaccines by Country

    • 8.1 Latin America Approved COVID-19 Vaccines Historic Market Size by Country
    • 8.1.1 Latin America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
  • 8.1.2 Latin America Approved COVID-19 Vaccines Sales in Value by Country (2017-2022)
  • 8.2 Latin America Approved COVID-19 Vaccines Forecasted Market Size by Country
  • 8.2.1 Latin America Approved COVID-19 Vaccines Sales in Volume by Country (2023-2028)
  • 8.2.2 Latin America Approved COVID-19 Vaccines Sales in Value by Country (2023-2028)
  • 9 Middle East and Africa Approved COVID-19 Vaccines by Country

    • 9.1 Middle East and Africa Approved COVID-19 Vaccines Historic Market Size by Country
    • 9.1.1 Middle East and Africa Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
  • 9.1.2 Middle East and Africa Approved COVID-19 Vaccines Sales in Value by Country (2017-2022)
  • 9.2 Middle East and Africa Approved COVID-19 Vaccines Forecasted Market Size by Country
  • 9.2.1 Middle East and Africa Approved COVID-19 Vaccines Sales in Volume by Country (2023-2028)
  • 9.2.2 Middle East and Africa Approved COVID-19 Vaccines Sales in Value by Country (2023-2028)
  • 10 Company Profiles and Key Figures in Approved COVID-19 Vaccines Business

    • 10.1 Moderna
    • 10.1.1 Moderna Corporation Information
  • 10.1.2 Moderna Introduction and Business Overview
  • 10.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.1.4 Moderna Approved COVID-19 Vaccines Products Offered
  • 10.1.5 Moderna Recent Development
  • 10.2 CanSino Biologicals
  • 10.2.1 CanSino Biologicals Corporation Information
  • 10.2.2 CanSino Biologicals Introduction and Business Overview
  • 10.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.2.4 CanSino Biologicals Approved COVID-19 Vaccines Products Offered
  • 10.2.5 CanSino Biologicals Recent Development
  • 10.3 Inovio Pharmaceuticals
  • 10.3.1 Inovio Pharmaceuticals Corporation Information
  • 10.3.2 Inovio Pharmaceuticals Introduction and Business Overview
  • 10.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Products Offered
  • 10.3.5 Inovio Pharmaceuticals Recent Development
  • 10.4 Shenzhen Geno-Immune Medical Institute
  • 10.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
  • 10.4.2 Shenzhen Geno-Immune Medical Institute Introduction and Business Overview
  • 10.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Products Offered
  • 10.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
  • 10.5 GlaxoSmithKine
  • 10.5.1 GlaxoSmithKine Corporation Information
  • 10.5.2 GlaxoSmithKine Introduction and Business Overview
  • 10.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Products Offered
  • 10.5.5 GlaxoSmithKine Recent Development
  • 10.6 Pfizer
  • 10.6.1 Pfizer Corporation Information
  • 10.6.2 Pfizer Introduction and Business Overview
  • 10.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.6.4 Pfizer Approved COVID-19 Vaccines Products Offered
  • 10.6.5 Pfizer Recent Development
  • 10.7 Johnson&Johnson
  • 10.7.1 Johnson&Johnson Corporation Information
  • 10.7.2 Johnson&Johnson Introduction and Business Overview
  • 10.7.3 Johnson&Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.7.4 Johnson&Johnson Approved COVID-19 Vaccines Products Offered
  • 10.7.5 Johnson&Johnson Recent Development
  • 10.8 Heat Biologics
  • 10.8.1 Heat Biologics Corporation Information
  • 10.8.2 Heat Biologics Introduction and Business Overview
  • 10.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.8.4 Heat Biologics Approved COVID-19 Vaccines Products Offered
  • 10.8.5 Heat Biologics Recent Development
  • 10.9 Sanofi
  • 10.9.1 Sanofi Corporation Information
  • 10.9.2 Sanofi Introduction and Business Overview
  • 10.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2017-2022)
  • 10.9.4 Sanofi Approved COVID-19 Vaccines Products Offered
  • 10.9.5 Sanofi Recent Development
  • 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis

    • 11.1 Approved COVID-19 Vaccines Key Raw Materials
    • 11.1.1 Key Raw Materials
  • 11.1.2 Key Raw Materials Price
  • 11.1.3 Raw Materials Key Suppliers
  • 11.2 Manufacturing Cost Structure
  • 11.2.1 Raw Materials
  • 11.2.2 Labor Cost
  • 11.2.3 Manufacturing Expenses
  • 11.3 Approved COVID-19 Vaccines Industrial Chain Analysis
  • 11.4 Approved COVID-19 Vaccines Market Dynamics
  • 11.4.1 Approved COVID-19 Vaccines Industry Trends
  • 11.4.2 Approved COVID-19 Vaccines Market Drivers
  • 11.4.3 Approved COVID-19 Vaccines Market Challenges
  • 11.4.4 Approved COVID-19 Vaccines Market Restraints
  • 12 Market Strategy Analysis, Distributors

    • 12.1 Sales Channel
    • 12.2 Approved COVID-19 Vaccines Distributors
    • 12.3 Approved COVID-19 Vaccines Downstream Customers

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
    • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
    • 14.2 Author Details
    • Summary:
      Get latest Market Research Reports on Approved COVID-19 Vaccines. Industry analysis & Market Report on Approved COVID-19 Vaccines is a syndicated market report, published as Global Approved COVID-19 Vaccines Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Approved COVID-19 Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,349.00
      4,698.00
      2,723.10
      5,446.20
      448,804.00
      897,608.00
      241,860.00
      483,720.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report